trees.cloudBlogtrees.cloud →

Cannabis stocks today: Friday, Nov 13, 2026

Cannabis stocks recap: MSOS fell 5.4% on Thursday to $3.86, and Curaleaf dropped 9.1%, as only 2 of 17 cannabis names finished higher.

Trees.Cloud Research

· 2 min read

ShareLinkedInXFacebook
Cannabis stock winners and losers chart for Friday, Nov 13, 2026

Here is today's cannabis stocks recap, with the winners, the losers and the news behind the moves. MSOS fell 5.4% on Thursday to $3.86, and Curaleaf dropped 9.1%, as only 2 of 17 cannabis names finished higher.

ETFs, Thursday: MSOS −5.4% to $3.86, CNBS −4.6%, MJ −4.0%, YOLO −3.8%. Of 17 liquid names above $50M, 2 rose and 15 fell.

Winners

  • Auxly (CBWTF): +1.6% to $2.55, the day it reported Q3 results
  • NewLake Capital (NLCP): +0.1% to $13.87

Losers

  • Curaleaf (CURLF): −9.1% to $8.06
  • Village Farms (VFF): −5.6% to $2.54
  • Green Thumb (GTBIF): −5.5% to $6.22
  • Turning Point Brands (TPB): −5.2% to $55.75, near its 52-week low of $54.17
  • Canopy Growth (CGC): −5.2% to $0.57, near its 52-week low of $0.56

Canadian LPs: Tilray −4.6% to $2.49, near its 52-week low of $2.47; Organigram −2.3% to $0.83, near its 52-week low of $0.82; SNDL −2.1%; Aurora, High Tide and Cronos each about −1.2%. Lenders and landlords: AFC Gamma −4.8%, Innovative Industrial Properties −3.8% to $52.66, NewLake +0.1%.

How the news lined up

  • The first phase of the federal hemp ban took effect Thursday, and Turning Point Brands fell 5.2%.
  • US operators fell the day after reports that the DEA has rejected medical marijuana registrations in at least six states and D.C.
  • We found no company news behind Curaleaf's 9.1% drop.

These are correlations, not proof of cause.

Is the DEA's denial list weighing on US operators more than reform hopes are lifting them?

Not investment advice.

Sources: trees.cloud stock data (Thu Nov 12 close). Federal hemp ban, phase one (Marijuana Moment): https://www.marijuanamoment.net/first-phase-of-renewed-federal-hemp-product-ban-takes-effect-as-industry-pushes-congress-for-regulatory-alternative/ DEA denials (Marijuana Moment): https://www.marijuanamoment.net/dea-is-rejecting-medical-marijuana-businesses-that-want-federal-rescheduling-protections-in-multiple-states/ Auxly Q3 (Benzinga): https://www.benzinga.com/news/26/11/63196019/auxly-cannabis-group-q3-2026-earnings-call-transcript

#cannabisstocks #MSOS #cannabisindustry #investing

Keep reading